ATE177944T1 - Pellets - Google Patents

Pellets

Info

Publication number
ATE177944T1
ATE177944T1 AT95922430T AT95922430T ATE177944T1 AT E177944 T1 ATE177944 T1 AT E177944T1 AT 95922430 T AT95922430 T AT 95922430T AT 95922430 T AT95922430 T AT 95922430T AT E177944 T1 ATE177944 T1 AT E177944T1
Authority
AT
Austria
Prior art keywords
cores
pharmaceutical
preparation
coating
pellets
Prior art date
Application number
AT95922430T
Other languages
English (en)
Inventor
Tomas Norling
Lone Norgaard Jorgensen
Jens Hansen
Original Assignee
Dumex Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Ltd As filed Critical Dumex Ltd As
Application granted granted Critical
Publication of ATE177944T1 publication Critical patent/ATE177944T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT95922430T 1994-06-15 1995-06-14 Pellets ATE177944T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK69594 1994-06-15

Publications (1)

Publication Number Publication Date
ATE177944T1 true ATE177944T1 (de) 1999-04-15

Family

ID=8096481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95922430T ATE177944T1 (de) 1994-06-15 1995-06-14 Pellets

Country Status (12)

Country Link
EP (1) EP0765157B1 (de)
AT (1) ATE177944T1 (de)
AU (1) AU697456B2 (de)
CA (1) CA2192086C (de)
DE (1) DE69508580T2 (de)
DK (1) DK0765157T3 (de)
ES (1) ES2131318T3 (de)
FI (1) FI118675B (de)
GR (1) GR3030256T3 (de)
NO (1) NO315544B1 (de)
NZ (1) NZ288185A (de)
WO (1) WO1995034291A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
ITMI20011632A1 (it) * 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
DE10221726A1 (de) * 2002-05-16 2003-11-27 Sachtleben Chemie Gmbh Verwendung von Röntgenbaryt als Zusatz-und/oder Hilfsstoff bei der Herstellung von Arzneimitteln, Lebensmitteln und Kosmetika
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
CA2549642C (en) 2003-12-31 2012-10-30 Cima Labs Inc. Effervescent oral opiate dosage forms and methods of administering opiates
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
EP1834634A3 (de) * 2006-03-08 2007-10-03 Rentschler Pharma GmbH Aus mehrfacher Einzeleinheiten bestehender pharmazeutische Zusammensetzung
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
EP2598123A1 (de) * 2010-07-27 2013-06-05 Norgine BV Zusammensetzungen
JP5578534B2 (ja) * 2010-12-27 2014-08-27 富田製薬株式会社 製剤用崩壊型核粒子
US10405568B2 (en) * 2012-11-19 2019-09-10 Tracy L. Lundberg Flowable food composition with water-holding and lubricating agents
CN117049933B (zh) * 2023-08-11 2025-02-18 西北大学 一种可热塑成型的复合钨系延期药及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292747A2 (fr) * 1973-09-14 1976-06-25 Gewerk Victor Chem Werke Procede de preparation de carbonate de calcium de grande finesse et de masse volumique elevee, aisement dispersable
US4096246A (en) * 1976-10-06 1978-06-20 A/S Apothekernes Laboratorium For Specialpraeparater Zinc bacitracin composition for use as a feed supplement and method for making the same
US4164572A (en) * 1976-10-06 1979-08-14 A/S Apothekernes Laboratorium For Specialpraeparater Zinc bacitracin composition for use as a feed supplement and method for making the same
JPS5823361B2 (ja) * 1976-10-26 1983-05-14 クミアイ化学工業株式会社 顆粒状農薬の製造法
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
JPH04283520A (ja) * 1991-03-12 1992-10-08 Asahi Chem Ind Co Ltd 球状核および球形顆粒

Also Published As

Publication number Publication date
NZ288185A (en) 1998-02-26
DE69508580D1 (en) 1999-04-29
CA2192086C (en) 2000-01-25
NO965381L (no) 1997-02-13
NO965381D0 (no) 1996-12-13
FI965003A0 (fi) 1996-12-13
AU697456B2 (en) 1998-10-08
EP0765157A1 (de) 1997-04-02
CA2192086A1 (en) 1995-12-21
HK1010335A1 (en) 1999-06-17
DK0765157T3 (da) 1999-10-25
FI965003L (fi) 1996-12-13
AU2732795A (en) 1996-01-05
WO1995034291A1 (en) 1995-12-21
FI118675B (fi) 2008-02-15
GR3030256T3 (en) 1999-08-31
DE69508580T2 (de) 1999-09-23
NO315544B1 (no) 2003-09-22
EP0765157B1 (de) 1999-03-24
ES2131318T3 (es) 1999-07-16

Similar Documents

Publication Publication Date Title
DK0765157T3 (da) Pellets
ATE30380T1 (de) Pharmazeutische formulierungen mit mehrfachen einheiten.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
CA2025703A1 (en) Pulsatile once-a-day delivery systems for minocycline
NO20011211D0 (no) Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasøytiske preparater og fremgangsmÕter for fremstilling av samme
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
EP1352896A3 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
ATE367802T1 (de) Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
AR066313A2 (es) Una formulacion de liberacion controlada de galantamina, una forma farmaceutica de dosificacion, un proceso para la preparacion de dicha formulacion, y el uso de dicha formulacion para la manufactura de un medicamento
JPS63258406A (ja) 持続放出製剤
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
DE69817010D1 (de) Spheroide, verfahren zu ihrer herstellung und diese enthaltende arzneiformen
KR20110025833A (ko) 활성제의 일정한 (0-차) 방출을 위한 방출 시스템의 조성물 및 제조방법
MY124599A (en) Oral suspension of pharmaceutical substance
CY1108863T1 (el) Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
DE59305805D1 (de) Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0305968A3 (de) Zusammensetzungen gegen Protozoenerkrankungen
WO2009006299A2 (en) Multi-particulate systems
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
DK472886D0 (da) Fremgangsmaade til fremstilling af et granulat ved samtidig taerringog granulering af ekstraktstoffer fra for aeggehvidestof befriet kalveblod og anvendelse af granulatet til fremstilling af farmaceutiske praeparater
EP0781135A4 (de) Codein enthaltende formulierungen
US20190275100A1 (en) Application of longhu rendan in preparing medicament for preventing and/or treating liver fibrosis
Park et al. Clinical trial of cefotaxime in patients with typhoid fever
JP4945869B2 (ja) 免疫賦活剤
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification